
News Releases / Full Story

April 27, 2009
Migraine Study for Kids & Teens Available in Madison
Treating Migraines Can Improve an Adolescent’s Grades & Mood
Madison, WI - Migraine headaches are common among kids and teenagers. However, children who suffer from migraines tend to get more of them as they get older, making it even more important to control migraines early on.
Dean Foundation is enrolling adolescents between the ages of 12 and 17-years-old for a clinical research study of an investigational medication to treat moderate to severe migraine headaches. Participants must report suffering two to eight migraine attacks per month for the last six months to be considered for enrollment in the study.
Pain, sensitivity to light, nausea and even vomiting are symptoms of migraines. Although these strong and painful headaches do not last as long as adult migraines, they still get in the way of day-to-day activities.
Kids and teenagers who suffer from migraines often miss both school and their extra-curricular activities. They may suffer from increased tiredness and moodiness, causing a negative effect on your whole family's quality of life.
Currently, there are no FDA-approved treatment options available for kids and teenagers who have migraines. Researchers therefore continue to look for medications that will work safely and effectively in treating migraine headaches among kids and teenagers.
The current clinical trial being conducted at Dean Foundation evaluates the efficacy of a range of doses of an investigational combination product containing sumatriptan and naproxen sodium. Both drugs are approved by the FDA for the treatment of migraines in adults. Studies like this are important parts of the research involved in developing safe and effective new medications and treatments. As the sponsor of this study, GlaxoSmithKline Pharmaceuticals is conducting research in several states throughout the United States. Dean Foundation in Madison is proud to be one of those research sites.
For more information on eligibility and enrollment, visit www.dean.org or call (608) 827-2333. To arrange an interview with lead investigators Leslie Taylor, MD or Mary Dominski, MD, contact Communications Manager Melissa Wollering at (608) 250-1504.









